ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/07/2026
Voltar para busca
Dado oficial do USPTO
NIGHT FEVER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
02/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
03/10/2006
Data de registro
12/02/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/09/2014
Última transação
02/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
FR
Examinador
BELZER, LYDIA M
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BIOFAR
BIOFAR
Representantes
John Alumit ALUMIT IP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for enhancing energy productionparapharmaceutical preparations for enhancing energy productiondietetic foods adapted for medical and paramedical usedietary food supplements for medical or paramedical useeach of which contain one or more of the followingproteinscarbohydrateslipidsfibersmicronutrients such as vitamins or mineralsamino acidsfatty acidsall available in individual dosessuch as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powdersgranular powderscellulose microspheres impregnated with active depurative ingredients; pharmaceutical preparations and parapharmaceutical preparations for enhancing energy productionall made from plantsextracts of plantsvegetable extractsavailable in effervescent or other forms; pharmaceutical preparations and parapharmaceutical preparations for the treatment of enhancing energy productionall containing minerals or vitaminsavailable in effervescent or other forms; vitamins and mineral supplements in effervescent or other forms; pharmaceutical preparations and parapharmaceutical preparations based on phytotherapyfor enhancing energy production; food supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use as additions to the nutrient intake in a normal dietwhich contain one or more of the followingproteinscarbohydrateslipidsfibersmicronutrients such as vitamins or mineralsamino acidsfatty acidsavailable in individual dosessuch as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powdersgranular powderscellulose microspheres impregnated with active depurative ingredients; all dietetic foods adapted for medical and paramedical usewhich contain one or more of the followingproteinscarbohydrateslipidsfibersmicronutrients such as vitamins or mineralsamino acidsfatty acidsavailable in individual dosessuch as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powdersgranular powderscellulose microspheres impregnated with active depurative ingredients; food supplements for medical use prepared for human consumption from food ingredients of vegetable or mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable or mineral originwhich contain one or more of the followingproteinscarbohydrateslipidsfibersmicronutrients such as vitamins or mineralsamino acidsfatty acidsavailable in individual dosessuch as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powdersgranular powderscellulose microspheres impregnated with active depurative ingredients; fortifying foodstuffs adapted for medical use; fortifying foodstuffs adapted for paramedical use and which contain one or more of the followingproteinscarbohydrateslipidsfibersmicronutrients such as vitamins or mineralsamino acidsfatty acidsavailable in individual dosessuch as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powdersgranular powderscellulose microspheres impregnated with active depurative ingredients
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
RFNT
REFUSAL PROCESSED BY IB
11/12/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/11/2016
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
28/08/2015
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/08/2015
INPC
INVALIDATION PROCESSED
05/08/2015
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
19/05/2015
C71T
CANCELLED SECTION 71
19/09/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/05/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/08/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/05/2008
FIMP
FINAL DISPOSITION PROCESSED
14/05/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/05/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2008
PUBO
PUBLISHED FOR OPPOSITION
27/11/2007
NPUB
NOTICE OF PUBLICATION
07/11/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/10/2007
ALIE
ASSIGNED TO LIE
23/10/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/09/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/08/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/08/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/08/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/08/2007
RFNT
REFUSAL PROCESSED BY IB
15/03/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/02/2007
RFRR
REFUSAL PROCESSED BY MPU
28/02/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/02/2007
CNRT
NON-FINAL ACTION WRITTEN
27/02/2007
DOCK
ASSIGNED TO EXAMINER
20/02/2007
NWAP
NEW APPLICATION ENTERED
05/01/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/01/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NIGHT FEVER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.